OFIX News and Press, Orthofix Medical Inc. From 01/19/22

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and nView medical, a Salt Lake City-based company developing surgical imaging and guidance systems enabled by artificial intelligence (AI), today announced a partnership and inv...

Fourth quarter net sales of approximately $125 million, an increase of 11% sequentially and 6% versus the prior year 2021 annual net sales of approximately $464 million, an increase of 14% versus the prior year Double-digit growth over the prior year period...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company’s Board of Directors and appointed to the Compensation and Talent Development Committee. This press ...

Surgalign reported GAAP EPS of -$0.06 (versus -$0.36 in the prior-year quarter) and missed revenues by $2.65M for FY 2021 Q3. The company guided for lower FY 2021 revenues by $7M to $8M on the bottom/top range, for total revenues of $88M to $92M for the year. The diction regarding...

Image source: The Motley Fool. Orthofix Medical inc (NASDAQ: OFIX) Q3 2021 Earnings Call Nov 5, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Orthofix Medical inc (OFIX) Q3 2021 Earnings Call Transcript

Orthofix Medical Inc. (OFIX) Q3 2021 Earnings Conference Call November 05, 2021 08:30 AM ET Company Participants Alexa Huerta - Senior Director of Investor Relations Jon Serbousek - President & Chief Executive Officer Doug Rice - Chief Financial Officer Conference Call Participants Mathew...

Orthofix (NASDAQ:OFIX): Q3 Non-GAAP EPS of $0.10 beats by $0.01; GAAP EPS of -$0.11 beats by $0.03. Revenue of $112.43M (+1.3% Y/Y) misses by $0.88M. Press Release For further details see: Orthofix EPS beats by $0.01, misses on revenue

Net sales of $112 million, an increase of 1.3% over the prior year period Double-digit growth over the prior year period for both global Spinal Implants and Orthopedics More than 1,000 U.S. surgeons trained and 60,000 M6-C artificial cervical discs implante...

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in two upcoming virtual investor conferences. Cr...

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the third quarter 2021 before market open on Friday, November 5, 2021. Jon Serbousek, President and Chief Executive Off...